ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells.

Hiroyuki Ozawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.